Navigation Links
Labopharm to present at Cowen 30th Annual Health Care Conference
Date:3/3/2010

quired to join the webcast. An audio archive of the presentation will be available for 30 days.

About Labopharm Inc.

Headquartered in Laval, Canada with US offices in Princeton, New Jersey, Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets and Australia. Its second product, OLEPTRO(TM), a novel formulation of trazodone for the treatment of major depressive disorder in adults, has received regulatory approval in the U.S. and is under regulatory review in Canada. Labopharm has initiated the European regulatory approval process for its third product, a twice-daily formulation of tramadol-acetaminophen. The Company also has a pipeline of follow-on products in both pre-clinical and clinical development.

SOURCE Labopharm Inc.

Back to top
'/>"/>
SOURCE Labopharm Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm announces underwriters exercise of over-allotment option for recent public offering
2. Labopharm announces closing of US$20 million public offering of units
3. Labopharm announces pricing of US$20 million public offering of units
4. Labopharm settles $1 million draw down under standby equity distribution agreement
5. Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe
6. Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement
7. Labopharm Reports Results for Third Quarter Fiscal 2009
8. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
9. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
10. Labopharm submits response to FDA for novel antidepressant
11. Labopharm Reports Results for Second Quarter Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... A ... partnership has earned international recognition as a premier center for treatment of and ... sudden, catastrophic internal bleeding and stroke. , Cure HHT, previously known as ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com ... Atlanta to help support childhood cancer research. On June 17, 2014, the ... Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very ...
(Date:9/2/2015)... ... September 02, 2015 , ... A ... is taking action after seeing a significant increase in unlawful tactics used by ... has found many cases of OON ASCs encouraging members to have elective procedures ...
(Date:9/2/2015)... Florida (PRWEB) , ... September 02, 2015 , ... A ... drug prices over the past year and its negative impact on consumers. It was ... prescription medication and 10% were paying as much as an extra $100 compared to ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg Innovations, ... surgical market, announced today that more than 600 successful patient procedures have been ... Plus, nearly 70 of these procedures have been on triggering thumbs. ...
Breaking Medicine News(10 mins):Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2
... grow old in good health should have strong grip, not ... recent study.// ,A 40-year study of nearly 6000 ... nine factors that were good predictors of which middle-aged men ... ,The nine factors were: not being overweight, low blood sugar ...
... disease in a whole new way, an experimental ... (ITP) once again// produce healthy amounts of platelets ... ,That's the conclusion of a new, multicenter study ... pediatrics at Weill Cornell Medical College, attending pediatrician ...
... progeny are dependant on a fairly simple factor - ... to impact the genes of the future generation//. In ... mice were seen to impact generation of offsprings. The ... of Sciences., ,To quote the researchers,” Although researchers ...
... project which aims at early detection of Alzheimer's and ... //Flagship, a CSIRO program of health research, in Australia. ... Alzheimer's disease, which currently affects 150,000 Australians. ... Emission Tomography (PET scans) on 1000 volunteers from Victoria ...
... of colorectal cancer screening appears to be increasing among ... common than other screening procedures// , according to a ... that younger veterans with other illnesses and reduced life ... may even be harmed, but continue to be screened ...
... up with incriminating evidence that warns non-vegetarians who binge on ... pointed out that eating more than one and a half ... related breast cancer and another study that vitamin supplements ... heart diseases except for vitamin C which seems to show ...
Cached Medicine News:Health News:Keys to Good Health in Old Age Begins in Midlife 2Health News:Drug Boosts Platelet Production, Reversing Immune Thrombocytopenic Purpura 2Health News:Drug Boosts Platelet Production, Reversing Immune Thrombocytopenic Purpura 3Health News:Studies Examine Colorectal Cancer Screening Rates 2Health News:Studies Examine Colorectal Cancer Screening Rates 3Health News:Studies Examine Colorectal Cancer Screening Rates 4Health News:Red alert to women against red meat consumption 2
(Date:9/2/2015)... Physicians Rx Pharmacy ("PRxP") today announced that ... President and Chief Executive Officer.  Mr. Bernstein, ... Officer for Soleo Health Specialty Infusion Services, will, as ... be responsible for leading the rapidly-growing 340B pharmacy services ... Gaston on as the President and CEO of PRxP," ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has ... (London, UK - November 19-20, 2015)" conference to ... will cover industry case studies, regulatory updates, latest therapies ... Dr Steven Nichols , OINP Specialist Consultant and ... Companies participating include: - Aptar ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ) has announced the addition of ... 16-18, 2015)" conference to their offering. Regulatory requirements for ... Peru , Brazil , ... , Paraguay , Venezuela , ... Chile This seminar can be viewed both as ...
Breaking Medicine Technology:Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2
... , , , ... to get all their flu shots as soon as the vaccines ... flu and the H1N1 (swine) flu, according to eight leading national ... eight organizations - the March of Dimes, the American College of ...
... , , , ... FRANCISCO, Sept. 23 Late-breaking data from the SPIRIT IV trial ... achieved superiority in the key safety and efficacy measures of target ... TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) at one year. With ...
Cached Medicine Technology:Pregnant Women Need Flu Shots 2Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 2Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 3Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 4Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 5Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial 6
Manual Lensmeter....
The Marco Lensmeter 201 features internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult....
... million pixel image provides excellent ... for all types of diagnostic ... glaucoma to diabetic retinopathy evaluation. ... filmless, instant review, digital filing ...
Manual lensmeter with AO target, high and wide field eyepiece and better marking dots....
Medicine Products: